Tuesday, 19 Jun 2018

You are here

Prevalence of Arthritis Grossly Underestimated

Researchers at the Boston University School of Medicine have published a new report showing that arthritis affected 91 million adults in the US in 2015 or 37% of the poplulation. Their prevalence estimate is 68% higher than previously reported arthritis national estimates. (Citation source: https://buff.ly/2hWzUxf+)

Prior national estimates of arthritis rely on a single survey question, asking the patient if they have ever been told they have arthritis by a health professional. Jafarzadeh and Felson took this a step further to assess prevalence based on a combination of factors - doctor-diagnosed arthritis, chronic joint symptoms, and whether symptom duration exceeded three months.

They analyzed 33,672 participants in the 2015 National Health Interview Survey (NHIS) and found that arthritis affects a much higher percentage of the US adult population, particularly underestimating arthritis in younger adults (<65 years old).

19.3 percent of men and 16.7 percent of women age18-64 years reported joint symptoms without a concurrent report of a doctor-diagnosed arthritis. For participants 65 years of age and older, the respective proportions were 15.7 percent and 13.5 percent.

 

Men

<65yrs

Women

<65 yrs

Men

>65yrs

Women

>65yrs

Joint Sxs

(with "arthritis" Dx

19.3%16.7%15.7%13.5%
"Arthritis" Dx by MD29.9%31.2%55.8%68.7%

 

The authors suggest that current arthritis surveillance methods should be revised to correct for inherent limitations and to increase accuracy.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Update on Osteoporosis

This session was an update on the management of osteoporosis given by Professor Christian Roux from France.

He emphasised the use of composite risk score like the FRAX. He highlighted that the risk of vertebral fracture is increased by both the recency and severity of previous vertebral fracture. So it is important that those with vertebral fractures are followed up and treated appropriately to prevent subsequent fractures.

Restless Sleep and Inactivity Intertwined in OA

Adults with osteoarthritis (OA) of the knee who frequently experienced restless sleep were less likely to engage in potentially beneficial moderate-to-vigorous physical activity, analysis of data from the Osteoarthritis Initiative found.

FDA Approves Denosumab for Glucocorticoid-Induced Osteoporosis

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the use of Prolia® (denosumab) for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

Bisphosphonate Drug Holidays May Result in Fractures

A report in Endocrine Practice shows that drug holidays from bisphosphonates results in a 15% risk of fractures.  (Citation source: http://bit.ly/2FHbFwp)

USPSTF Recommendations on Vitamin D, Calcium Supplementation to Prevent Fractures

The U.S. Preventive Services Task Force (USPSTF) concludes current scientific evidence is insufficient regarding the use of vitamin D and calcium, alone or in combination, to prevent fractures in men and premenopausal women. The USPSTF recommends against daily supplementation with 400 IU or less of vitamin D and 1,000 mg or less of calcium to prevent fractures in postmenopausal women. Current scientific evidence is insufficient regarding the use of vitamin D and calcium at doses greater than 400 IU of vitamin D and greater than 1,000 mg of calcium in postmenopausal women.